What is a stock summary page? Click here for an overview.
Business Description
Medacta Group SA
ISIN : CH0468525222
Share Class Description:
MEDGF: Ordinary SharesDescription
Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 1.48 | |||||
| Interest Coverage | 11.85 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.19 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.5 | |||||
| 3-Year EBITDA Growth Rate | 13.4 | |||||
| 3-Year EPS without NRI Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | 14.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 14.54 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.05 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 427.64 | |||||
| Days Sales Outstanding | 63.18 | |||||
| Days Payable | 75.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.16 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -0.2 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.65 | |||||
| Operating Margin % | 15.37 | |||||
| Net Margin % | 12.35 | |||||
| FCF Margin % | 0.35 | |||||
| ROE % | 20.8 | |||||
| ROA % | 9.88 | |||||
| ROIC % | 11.27 | |||||
| 3-Year ROIIC % | 6.35 | |||||
| ROC (Joel Greenblatt) % | 18.4 | |||||
| ROCE % | 16.43 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.95 | |||||
| Forward PE Ratio | 18.25 | |||||
| PE Ratio without NRI | 37.95 | |||||
| Shiller PE Ratio | 57.01 | |||||
| Price-to-Owner-Earnings | 38.2 | |||||
| PEG Ratio | 2.05 | |||||
| PS Ratio | 4.69 | |||||
| PB Ratio | 7.38 | |||||
| Price-to-Tangible-Book | 8.6 | |||||
| Price-to-Free-Cash-Flow | 1397.87 | |||||
| Price-to-Operating-Cash-Flow | 25.91 | |||||
| EV-to-EBIT | 31.11 | |||||
| EV-to-Forward-EBIT | 23.61 | |||||
| EV-to-EBITDA | 18.48 | |||||
| EV-to-Forward-EBITDA | 14.49 | |||||
| EV-to-Revenue | 5.03 | |||||
| EV-to-Forward-Revenue | 4.02 | |||||
| EV-to-FCF | 1479.73 | |||||
| Price-to-GF-Value | 0.87 | |||||
| Price-to-Projected-FCF | 7.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.01 | |||||
| Price-to-Graham-Number | 3.81 | |||||
| Earnings Yield (Greenblatt) % | 3.21 | |||||
| FCF Yield % | 0.07 | |||||
| Forward Rate of Return (Yacktman) % | 18.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MEDGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medacta Group SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 626.867 | ||
| EPS (TTM) ($) | 3.877 | ||
| Beta | -0.26 | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -0.83 | ||
| Volatility % | 0.72 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 83.91 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 83.91 - 83.91 | ||
| Shares Outstanding (Mil) | 19.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medacta Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medacta Group SA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medacta Group SA Frequently Asked Questions
What is Medacta Group SA(MEDGF)'s stock price today?
The current price of MEDGF is $83.91. The 52 week high of MEDGF is $83.91 and 52 week low is $83.91.
When is next earnings date of Medacta Group SA(MEDGF)?
The next earnings date of Medacta Group SA(MEDGF) is 2025-09-08.
Does Medacta Group SA(MEDGF) pay dividends? If so, how much?
Medacta Group SA(MEDGF) does not pay dividend.
Guru Commentaries on OTCPK:MEDGF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers